ciprofloxacin has been researched along with coumermycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elie, C; Forterre, P; Possot, O; Sibold, L; Sioud, M | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Aldridge, KE; Janney, A; Sanders, CV | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Joly, P; Van der Auwera, P | 1 |
| Glauser, MP; Malinverni, R; Perronne, CM | 1 |
| Howard, BM; Pinney, RJ; Smith, JT | 2 |
8 other study(ies) available for ciprofloxacin and coumermycin
| Article | Year |
|---|---|
Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme.
Topics: Aminocoumarins; Anti-Bacterial Agents; Archaea; Autoradiography; Bacteria; Ciprofloxacin; Coumarins; DNA Replication; DNA Topoisomerases, Type II; Drug Interactions; Electrophoresis, Agar Gel; Euryarchaeota; Halobacterium; Novobiocin; Plasmids | 1988 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteriophage Typing; Ciprofloxacin; Coumarins; Glycopeptides; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus aureus; Teicoplanin | 1985 |
In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Aminocoumarins; Anti-Bacterial Agents; Ciprofloxacin; Coumarins; Drug Combinations; Microbial Sensitivity Tests; Quinolines; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Staphylococcus epidermidis | 1986 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
Topics: Aminocoumarins; Animals; Ciprofloxacin; Cloxacillin; Coumarins; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Rats; Staphylococcal Infections; Staphylococcus aureus | 1987 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
Topics: Aminocoumarins; Ciprofloxacin; Coumarins; Drug Resistance, Microbial; Escherichia coli; Mutation; Novobiocin; Phenotype; Staphylococcus | 1993 |